Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant Models
Despite significant improvements in revascularization strategies and medical management, ischemic heart disease (IHD) remains the top cause of mortality and disability worldwide. The myocardium lacks regenerative capacity and consequently, recovery depends on re-establishing microvascular integrity...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2026-01-01
|
| Col·lecció: | Bioengineering |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2306-5354/13/1/81 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|